Product Description
Mechanisms of Action: HCV-NS5B Inhibitor
Novel Mechanism: No
Modality: Small Molecule
Route of Administration: Oral
FDA Designation: *
Approval Status: Not Approved
Approved Countries: None
Approved Indications: None
Known Adverse Events: None
Company: Boehringer Ingelheim
Company Location:
Company CEO:
Additional Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Recent & Upcoming Milestones
Highest Development Phases
Phase 3: Hepatitis C, Chronic|Hepatitis A|Liver Cirrhosis|Hepatitis C
Phase 2: Hepatitis C, Chronic|Hepatitis A
Phase 1: Healthy Volunteers|Hepatitis C, Chronic|Hepatitis A|Kidney Diseases
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
Latest Trial Update Date |
Data Updated |
|---|---|---|---|---|---|---|---|
| NCT01858961 | P3 |
Withdrawn |
Hepatitis C, Chronic |
2016-07-01 |
2019-03-19 |
Treatments |
|
| 2012-003534-17 | P2 |
Completed |
Hepatitis C, Chronic |
2016-06-08 |
2022-03-13 |
Treatments |
|
| 2012-003533-41 | P3 |
Completed |
Liver Cirrhosis |
2015-01-22 |
2022-03-13 |
Treatments |
|
| HCVerso1 | P3 |
Completed |
Hepatitis C, Chronic |
2015-01-01 |
2019-03-19 |
Treatments |
|
| BI207127 in combination with faldaprevir and ribavirin in treatment naive HCV GT1 infected patients | P3 |
Completed |
Liver Cirrhosis|Hepatitis C, Chronic |
2014-11-16 |
2022-03-13 |
Treatments |
|
| 2009-018197-66 | P2 |
Completed |
Hepatitis C, Chronic |
2014-10-30 |
2022-03-13 |
Treatments |
|
| HCVerso3 | P2 |
Completed |
Hepatitis C, Chronic|Hepatitis A |
2014-10-01 |
2019-03-19 |
Treatments |
|
| Randomized Phase Ib/II | P2 |
Completed |
Hepatitis C, Chronic |
2014-10-01 |
2019-03-19 |
||
| HCV Genotype 1a | P2 |
Completed |
Hepatitis A|Hepatitis C, Chronic |
2014-05-01 |
2019-03-19 |
||
| HCVerso2 | P3 |
Completed |
Hepatitis C, Chronic|Hepatitis A |
2014-02-01 |
2019-03-19 |
Treatments |
|
| 2012-004544-30 | P3 |
Completed |
Hepatitis C |
2014-01-13 |
2022-03-13 |
Treatments |
|
| NCT01965431 | P1 |
Completed |
Healthy Volunteers |
2014-01-01 |
2024-11-27 |
Primary Endpoints|Treatments |
|
| NCT01983566 | P1 |
Terminated |
Healthy Volunteers |
2014-01-01 |
2019-03-20 |
||
| NCT01941615 | P1 |
Terminated |
Healthy Volunteers |
2014-01-01 |
2019-03-20 |
Treatments |
|
| NCT01957657 | P1 |
Terminated |
Kidney Diseases |
2013-12-01 |
2019-03-20 |
Treatments |
|
| NCT01525628 | P1 |
Completed |
Hepatitis A|Hepatitis C, Chronic |
2013-12-01 |
2019-03-19 |
||
| NCT01528735 | P2 |
Completed |
Hepatitis A|Hepatitis C, Chronic |
2013-08-01 |
2019-03-19 |
Treatments |
|
| NCT01737996 | P1 |
Completed |
Healthy Volunteers |
2013-03-01 |
2019-03-19 |
Treatments |
|
| NCT01605461 | P1 |
Completed |
Healthy Volunteers |
2012-06-01 |
2019-03-19 |
Treatments |
|
| NCT01535638 | P1 |
Completed |
Healthy Volunteers |
2012-03-01 |
2019-03-19 |
Treatments |
|
| NCT01347086 | P1 |
Completed |
Healthy Volunteers |
2011-06-01 |
2019-03-19 |
Treatments |
|
| NCT00905632 | P1 |
Completed |
Hepatitis C, Chronic |
2011-03-01 |
2019-03-18 |
||
| NCT02176525 | P1 |
Completed |
Hepatitis C, Chronic |
2009-12-01 |
2019-03-20 |
Treatments |
|
| NCT02182414 | P1 |
Completed |
Healthy Volunteers |
2009-09-01 |
2019-03-20 |
Treatments |
|
| NCT02182401 | P1 |
Terminated |
Healthy Volunteers |
2009-08-01 |
2019-03-20 |
Treatments |
Recent News Events
Date |
Type |
Title |
|---|